{"id":"W2908768956","doi":"10.1136/rmdopen-2018-000806","title":"Tofacitinib or adalimumab versus placebo: patient-reported outcomes from OPAL Broaden—a phase III study of active psoriatic arthritis in patients with an inadequate response to conventional synthetic disease-modifying antirheumatic drugs","year":2019,"lang":"en","type":"article","venue":"RMD Open","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Medicine; Tofacitinib; Adalimumab; Minimal clinically important difference; Placebo; Psoriatic arthritis; Ankylosing spondylitis; Internal medicine; Janus kinase inhibitor; Quality of life (healthcare); Physical therapy; Arthritis; Rheumatoid arthritis; Randomized controlled trial; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high","status":"direct model label, unvalidated"}],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005212231,0.002082708,0.003314123,0.0006053004,0.0005760679,0.001335013,0.001109858,0.001793806,0.004909224],"category_scores_gemma":[0.002570714,0.0006721696,0.003050255,0.0005554137,0.001036981,0.001112858,0.0006158075,0.003231768,0.0007282274],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006505033,"about_ca_system_score_gemma":0.001390652,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000709803,"about_ca_topic_score_gemma":0.001600581,"domain_scores_codex":[0.9979243,0.001319437,0.0001265125,0.0002137272,0.0001812646,0.0002347714],"domain_scores_gemma":[0.9980394,0.0005464667,0.0005659672,0.0001359023,0.0001201566,0.0005920462],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9665996,0.01289731,0.001639293,0.0006014866,0.00190298,0.00003832943,0.00006875113,0.0004013269,0.002310473,0.00004460745,0.0005150354,0.01298077],"study_design_scores_gemma":[0.861593,0.1273263,0.008166866,0.00004092646,0.001277135,0.00004376604,0.00003340858,0.0003772894,0.0004248681,0.00009137647,0.0006055724,0.00001955019],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9858103,0.006323772,0.0004253006,0.0004165278,0.0002012948,0.003238156,0.001765786,0.00006040607,0.001758466],"genre_scores_gemma":[0.9871275,0.002519727,0.001058693,0.0008501154,0.0004225241,0.004456776,0.001898809,0.0000190375,0.001646729],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005212231,"threshold_uncertainty_score":0.02756524,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03191572517226805,"score_gpt":0.3292522620125296,"score_spread":0.2973365368402616,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}